Healthcare & Pharmaceuticals
U.S. FDA authorizes third dose of Pfizer COVID-19 vaccine for older Americans
The U.S. Food and Drug Administration on Wednesday authorized a booster dose of the Pfizer Inc and BioNTech COVID-19 vaccine for those aged 65 and older and some high-risk Americans, paving the way for a quick rollout of the shots.
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on Thursday
Japan to double COVID-19 vaccine donations to other countries to 60 mln doses
Brazil regulator says adolescent death unrelated to Pfizer shot
The death of a 16-year-old who had a first dose of the Pfizer/BioNTech , vaccine against COVID-19 was due to a prior blood clot condition not related to the vaccine, Brazil's health regulator Anvisa said on Wednesday.